CAMP Q3 2023 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$350,000-99.5% YoY

Gross Profit

$350,000100.0% margin

Operating Income

-$12M-3525.1% margin

Net Income

-$12M-3341.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-99.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$722,000

Balance Sheet

Total Assets

$364M

Total Liabilities

$353M

Stockholders' Equity

$11M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$350,000	$73M	-99.5%
Gross Profit	$350,000	$29M	-98.8%
Operating Income	-$12M	-$5M	-131.1%
Net Income	-$12M	-$7M	-56.1%

Revenue Segments

Product

$37M60%

Application Subscriptions And Other Services

$24M40%

Geographic Segments

UNITED STATES

$33M53%

EMEA

$14M22%

Asia Pacific

$8M12%

Latin America

$5M9%

All Other

$2M4%